08.01.2015 Views

1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The data in the register represent <strong>sales</strong> and prescribing data but they cannot be taken as equivalent<br />

to taken drugs. Some of the prescribed and sold drugs will never be taken as prescribed and there is<br />

little knowledge about what happens to the drugs after purchase in a pharmacy. All purchases of<br />

prescribed drugs in a pharmacy are included in the register. There might be a minor proportion of<br />

drugs offered in outpatient clinics or by general practitioners, as free samples are given by drug<br />

companies, resulting in under-reporting. Given these considerations, there is no reason to assume<br />

that the Register of Medicinal Product Statistics should not be valid.<br />

Data about products and indications were obtained from the Danish Drug Index, which has been<br />

published yearly in the whole period. Danish Drug Information, owned by The Danish Association<br />

of the Pharmaceutical Industry, has published the Danish Drug Index.<br />

We performed a correlation coefficient analysis of the association between DDD <strong>sales</strong> numbers and<br />

number of products well knowing that it is not possible to conclude about causation. Thus the study<br />

can make it plausible that there is an association between the <strong>sales</strong> and marketing.<br />

We looked at all psychotropic drugs and the changes in <strong>sales</strong> pattern. This could be discussed,<br />

because they are very different drugs, e.g. antidementia drugs, antidepressants and hypnotics. This<br />

gave though an overview of the changes in <strong>sales</strong> patterns including treatment changes between<br />

drugs, e.g. between benzodiazepines and <strong>SSRI</strong>s, which together represented the main part of the<br />

<strong>sales</strong> of psychotropic drugs.<br />

By means of a combination of three data sets of the <strong>sales</strong> of psychotropic drugs it was possible to<br />

construct <strong>sales</strong> curve of psychotropic drugs in Denmark in the primary health care sector over a 37<br />

years period.<br />

Results<br />

The <strong>sales</strong> of psychotropic drugs have fluctuated considerably over time even though the prevalence<br />

of the diseases should be expected to be about the same (figure 1). When the total <strong>sales</strong> of<br />

psychotropics were split into drug groups, <strong>sales</strong> of group N05, which contains the benzodiazepines,<br />

25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!